(Q50081045)

24 February 2018

title

Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. (English)

1 reference

24 February 2018

0 references

Hütt P

1

1 reference

24 February 2018

Shchepetova J

2

1 reference

24 February 2018

Lõivukene K

3

1 reference

24 February 2018

Kullisaar T

4

1 reference

24 February 2018

Mikelsaar M

5

1 reference

24 February 2018

publication date

1 June 2006

1 reference

24 February 2018

Journal of Applied Microbiology

published in

1 reference

24 February 2018

volume

100

1 reference

24 February 2018

issue

6

1 reference

24 February 2018

page(s)

1324-1332

1 reference

24 February 2018

Characterization of intestinal lactobacilli as putative probiotic candidates

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Anti-microbial substances produced by food associated micro-organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Common errors in diagnosis and management of urinary tract infection. II: clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Two antioxidative lactobacilli strains as promising probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Potential uses of probiotics in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Probiotic bacteria: safety, functional and technological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02857.X

10.1111/J.1365-2672.2006.02857.X

21 January 2018

Identifiers

DOI

1 reference

24 February 2018

1 reference

24 February 2018